Babak, O.Y. and Lapshyna, K.A. 2020. The fibroblasts growth factor 21 study in patients with non-alcoholic fatty liver disease and hypertension comorbidities. Zaporozhye Medical Journal. 22, 2 (Apr. 2020). DOI:https://doi.org/10.14739/2310-1210.2020.2.200572.